simplyStocks
Zoetis
ZTS · NYSEAnimal Health
The economic chain
Follow the chain left → right, from inputs to end demand. Tap any company to trace its links.
Raw inputs
Equipment
Foundry
Chip design
Software
AI demand
—
Company details
Market cap
~$72B
P/E ratio
~27×
Div yield
1.7%
EPS (2025)
$6.02
Profit margin
~28%
Rev. growth
+2%
Revenue
$9.5B
Net income
$2.7B
In plain English
Zoetis is the world's largest pure-play animal-health company — the Pfizer spin-off that makes the parasite pills (Simparica Trio), itch treatments (Apoquel) and vaccines that keep pets and farm animals healthy. About 70% of its sales now come from dogs, cats and horses, with the rest from cattle, swine, poultry and fish — sold through vets and distributors, not to consumers directly.
In simple terms
What Zoetis really sells
Zoetis is the world's largest pure-play animal-health company — the Pfizer spin-off that makes the parasite pills (Simparica Trio), itch treatments (Apoquel) and vaccines that keep pets and farm animals healthy. About 70% of its sales now come from dogs, cats and horses, with the rest from cattle, swine, poultry and fish — sold through vets and distributors, not to consumers directly.
Tip · Click any company in the map to learn — in one sentence — what it actually does and why it matters.
Risk read
SteadierMore speculative
Why this rating?